Since 1996, The LAM Foundation has been funding significant research that has led to tremendous progress in the treatment options and a possible cure for lymphangioleiomyomatosis. Today, The LAM Foundation is the largest funder of LAM research, outside of the National Institutes of Health.
The LAM Foundation-funded research has led to many major discoveries, including:
- Evidence that LAM is genetic
- Identification of a LAM gene
- Molecular explanation for abnormal smooth muscle cell growth in LAM, which has led to new therapies for LAM
- FDA approved treatment for LAM
The LAM Foundation offers the following research awards and grants:
- Pilot and Feasibility Grant
- Career Development Research Grant
- Established Investigator Research Grant
- Clinical Research Grant
- Out of Cycle Grant Opportunities
Deadline: June 16 (REQUIRED letter of intent)